Literature DB >> 30865182

Measuring Adherence to Antiretroviral Therapy via Hair Concentrations in India.

Monica Gandhi1, Sarita Devi2, Peter Bacchetti3, Sara Chandy4, Elsa Heylen5, Nhi Phung1, Karen Kuncze1, Hideaki Okochi6, Ravi Kumar7, Anura V Kurpad2, Maria L Ekstrand4,5.   

Abstract

BACKGROUND: Objective adherence measures are of increasing interest in antiretroviral treatment (ART) monitoring. Hair ART levels predict virologic suppression, and hair is easy to collect and store. No previous study has examined hair levels in an India-based cohort or laboratory.
METHODS: Small hair samples were collected from HIV-positive participants on either efavirenz (EFV)-based or nevirapine (NVP)-based ART in a South India-based study. Hair samples were split and analyzed for EFV or NVP in the University of California, San Francisco -based Hair Analytical Laboratory and the analytic laboratory of the Division of Nutrition at St. John's Research Institute, Bangalore, India, using liquid chromatography/tandem mass spectrometry. Agreement (using Bland-Altman methods) and rank correlation between the 2 laboratories' hair levels were calculated. Rank correlation between self-reported adherence (SRA) over the previous month using a visual analog scale and hair ART levels was calculated.
RESULTS: Among 75 participants (38 on NVP; 37 on EFV), the correlation between NVP levels generated by the 2 laboratories was 0.66 (P < 0.0001) and between EFV levels was 0.87 (P < 0.0001). Measurements from St. John's Research Institute were usually within 20% of those from the University of California, San Francisco Hair Analytical Laboratory. SRA was essentially uncorrelated with hair antiretroviral levels for either drug (all correlations < 0.04). Hair levels showed variability in adherence although SRA was >85% in all participants.
CONCLUSIONS: Hair ART levels measured by both an India-based laboratory and the standard U.S.-based laboratory showed generally high agreement and correlation, demonstrating local capacity. As in many other cohorts, hair ART levels and SRA were not well-correlated, likely indicating limitations in self-report and the need for objective adherence monitoring in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30865182      PMCID: PMC6522327          DOI: 10.1097/QAI.0000000000001993

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  38 in total

1.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

2.  Achieving Viral Suppression in 90% of People Living With Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities.

Authors:  Jean B Nachega; Nadia A Sam-Agudu; Lynne M Mofenson; Mauro Schechter; John W Mellors
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

3.  Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment.

Authors:  Tariro D Chawana; Monica Gandhi; Kusum Nathoo; Bernard Ngara; Alexander Louie; Howard Horng; David Katzenstein; John Metcalfe; Charles F B Nhachi
Journal:  J Acquir Immune Defic Syndr       Date:  2017-09-01       Impact factor: 3.731

4.  Clinical pharmacology quality assurance for HIV and related infectious diseases research.

Authors:  R DiFrancesco; K Tooley; S L Rosenkranz; S Siminski; C R Taylor; P Pande; G D Morse
Journal:  Clin Pharmacol Ther       Date:  2013-03-26       Impact factor: 6.875

5.  A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.

Authors:  Monica Gandhi; Ruth M Greenblatt; Peter Bacchetti; Chengshi Jin; Yong Huang; Kathryn Anastos; Mardge Cohen; Jack A Dehovitz; Gerald B Sharp; Stephen J Gange; Chenglong Liu; Susan C Hanson; Bradley Aouizerat
Journal:  J Infect Dis       Date:  2012-08-20       Impact factor: 5.226

6.  Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry.

Authors:  Yong Huang; Monica Gandhi; Ruth M Greenblatt; Winnie Gee; Emil T Lin; Nicholas Messenkoff
Journal:  Rapid Commun Mass Spectrom       Date:  2008-11       Impact factor: 2.419

7.  Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial.

Authors:  Monica Gandhi; Peter Bacchetti; Igho Ofokotun; Chengshi Jin; Heather J Ribaudo; David W Haas; Anandi N Sheth; Howard Horng; Nhi Phung; Karen Kuncze; Hideaki Okochi; Raphael J Landovitz; Jeffrey Lennox; Judith S Currier
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

8.  Preexposure prophylaxis for HIV infection among African women.

Authors:  Lut Van Damme; Amy Corneli; Khatija Ahmed; Kawango Agot; Johan Lombaard; Saidi Kapiga; Mookho Malahleha; Fredrick Owino; Rachel Manongi; Jacob Onyango; Lucky Temu; Modie Constance Monedi; Paul Mak'Oketch; Mankalimeng Makanda; Ilse Reblin; Shumani Elsie Makatu; Lisa Saylor; Haddie Kiernan; Stella Kirkendale; Christina Wong; Robert Grant; Angela Kashuba; Kavita Nanda; Justin Mandala; Katrien Fransen; Jennifer Deese; Tania Crucitti; Timothy D Mastro; Douglas Taylor
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

9.  Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.

Authors:  Sanjiv M Baxi; Eric Vittinghoff; Peter Bacchetti; Yong Huang; Kata Chillag; Ryan Wiegand; Peter L Anderson; Robert Grant; Ruth M Greenblatt; Susan Buchbinder; Monica Gandhi; Albert Y Liu
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

10.  Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence.

Authors:  Monica Gandhi; Peter Bacchetti; Warren C Rodrigues; Matthew Spinelli; Catherine A Koss; Paul K Drain; Jared M Baeten; Nelly R Mugo; Kenneth Ngure; Leslie Z Benet; Hideaki Okochi; Guohong Wang; Michael Vincent
Journal:  EClinicalMedicine       Date:  2018-08-31
View more
  11 in total

Review 1.  Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions.

Authors:  Matthew A Spinelli; Jessica E Haberer; Peter R Chai; Jose Castillo-Mancilla; Peter L Anderson; Monica Gandhi
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

2.  Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria.

Authors:  Monica Gandhi; Babafemi Taiwo; Jacinta N Nwogu; Samuel O Ngene; Chinedum P Babalola; Adeniyi Olagunju; Andrew Owen; Saye H Khoo; Olayinka A Kotila; Baiba Berzins; Hideaki Okochi; Regina Tallerico
Journal:  AIDS Res Ther       Date:  2022-07-10       Impact factor: 2.846

3.  Social Support Mitigates Negative Impact of Food Insecurity on Antiretroviral Adherence Among Postpartum Women in Western Kenya.

Authors:  Mira Wang; Joshua D Miller; Shalean M Collins; Marianne V Santoso; Pauline Wekesa; Hideaki Okochi; Maricianah Onono; Sheri Weiser; Monica Gandhi; Sera L Young
Journal:  AIDS Behav       Date:  2020-10

4.  Simultaneous Determination of 6 Antiretroviral Drugs in Human Hair Using an LC-ESI+-MS/MS Method: Application to Adherence Assessment.

Authors:  Yan Wu; Liuxi Chu; Haoran Yang; Wei Wang; Quan Zhang; Jin Yang; Shan Qiao; Xiaoming Li; Zhiyong Shen; Yuejiao Zhou; Shuaifeng Liu; Huihua Deng
Journal:  Ther Drug Monit       Date:  2021-12-01       Impact factor: 3.681

5.  Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings.

Authors:  Monica Gandhi; Guohong Wang; Roger King; Warren C Rodrigues; Michael Vincent; David V Glidden; Tim R Cressey; Peter Bacchetti; Matthew A Spinelli; Hideaki Okochi; Oraphan Siriprakaisil; Virat Klinbuayaem; Nelly R Mugo; Kenneth Ngure; Paul K Drain; Jared M Baeten
Journal:  AIDS       Date:  2020-02-01       Impact factor: 4.632

6.  Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings.

Authors:  Tanakorn Apornpong; Beatriz Grinsztejn; Michael Hughes; Justin Ritz; Stephen J Kerr; Courtney V Fletcher; Kiat Ruxrungtham; Catherine Godfrey; Robert Gross; Evelyn Hogg; Carole L Wallis; Sharlaa Badal-Faesen; Mina C Hosseinipour; Rosie Mngqbisa; Breno R Santos; Sarita Shah; Laura J Hovind; Sajeeda Mawlana; Marije Van Schalkwyk; Nuntisa Chotirosniramit; Cecilia Kanyama; Nagalingeswaran Kumarasamy; Robert Salata; Ann C Collier; Monica Gandhi
Journal:  AIDS       Date:  2021-07-15       Impact factor: 4.632

7.  Anxiety and Worry About COVID-19 Infection are Associated with Less Confidence in Ability to Engage in Treatment: Results from a South India Cohort of People Living with HIV (PLWH).

Authors:  Maria L Ekstrand; Elsa Heylen; Matilda Pereira; Sara Chandy; Krishnamachari Srinivasan
Journal:  J Int Assoc Provid AIDS Care       Date:  2022 Jan-Dec

8.  High Acceptability of Donating Hair and Other Biological Samples for Research Among People Living with HIV in an Outpatient Clinic in Lagos, Nigeria.

Authors:  Ebiere C Herbertson; Cecile D Lahiri; Jacinta N Nwogu; Rebecca O Soremekun; Olubusola A Olugbake; Oliver C Ezechi; Alani S Akanmu; Monica Gandhi
Journal:  AIDS Res Hum Retroviruses       Date:  2021-04-15       Impact factor: 1.723

9.  Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 Study.

Authors:  Cindy Vavro; Theodore Ruel; Andrew Wiznia; Nicole Montañez; Keith Nangle; Joseph Horton; Ann M Buchanan; Eugene L Stewart; Paul Palumbo
Journal:  Antimicrob Agents Chemother       Date:  2021-10-25       Impact factor: 5.938

10.  Clinical Value of Emerging Bioanalytical Methods for Drug Measurements: A Scoping Review of Their Applicability for Medication Adherence and Therapeutic Drug Monitoring.

Authors:  Tanja R Zijp; Zamrotul Izzah; Daan J Touw; Job F M van Boven; Christoffer Åberg; C Tji Gan; Stephan J L Bakker
Journal:  Drugs       Date:  2021-11-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.